https://www.selleckchem.com/
Arterial thrombo-embolic complications (ATEC) are still common during and after non-cardiac arterial procedures (NCAP) despite the administration of (a fixed bolus of) heparin. These ATEC could be due to existing individual differences in heparin sensitivity. The purpose of this study was to evaluate the feasibility and safety of an ACT guided heparin dose protocol and to evaluate if a more effective target ACT can be achieved during NCAP. In this multi-center prospective study, 194 patients undergoing elective and non-elective NCAP were enrolled and receiv
お気に入り
コメント
シェア
